Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Single Arm Phase I/II Study of MK-3475 Combined With Vorinostat for Recurrent Unresectable and/or Metastatic Squamous Cell Head and Neck Cancer and Recurrent Unresectable and/or Metastatic Salivary Gland Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02538510
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:06.476717+00:00
Published At
2020-10-22T00:00:00+00:00
Record Updated At
2024-11-26
Results Posted At
2020-10-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Head and Neck Squamous Cell Carcinoma", "Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma", "Recurrent Nasopharynx Carcinoma", "Recurrent Salivary Gland Carcinoma", "Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary", "Stage III Major Salivary Gland Carcinoma", "Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma", "Stage III Nasopharyngeal Carcinoma", "Stage IV Nasopharyngeal Carcinoma", "Stage IVA Major Salivary Gland Carcinoma", "Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma", "Stage IVB Major Salivary Gland Carcinoma", "Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma", "Stage IVC Major Salivary Gland Carcinoma", "Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-11-26"
protocolSection.identificationModule.nctId
"NCT02538510"
protocolSection.identificationModule.officialTitle
"A Single Arm Phase I/II Study of MK-3475 Combined With Vorinostat for Recurrent Unresectable and/or Metastatic Squamous Cell Head and Neck Cancer and Recurrent Unresectable and/or Metastatic Salivary Gland Malignancies"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-10-22"

Study condition terms

  • Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Nasopharynx Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Salivary Gland Carcinoma (protocolSection.conditionsModule.conditions)
  • Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary (protocolSection.conditionsModule.conditions)
  • Stage III Major Salivary Gland Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Nasopharyngeal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IV Nasopharyngeal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVA Major Salivary Gland Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVB Major Salivary Gland Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVC Major Salivary Gland Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.